Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
Categories: News

NeuroRPM Inc. Announces FDA Clearance for NeuroRPM, the AI-Powered Remote Monitoring App for Parkinson’s Disease on Apple Watch

WASHINGTON–(BUSINESS WIRE)–NeuroRPM Inc., a digital health company, has received FDA clearance for NeuroRPM, a breakthrough product that uses AI and Apple Watch to continuously and passively monitor bradykinesia, tremor, and dyskinesia, the cardinal symptoms of Parkinson’s disease. The product includes the most advanced and comprehensive monitoring capabilities for Parkinson’s disease available on a wearable device, allowing for day-to-day tracking of the full range of disease symptoms.

“The clearance of NeuroRPM is a major milestone in the fight against Parkinson’s disease,” said Co-founder Dr. Alexander Ksendzovsky, also the Director of Functional Neurosurgery at the University of Maryland. “This technology will allow for unprecedented insights into the symptoms of Parkinson’s disease including bradykinesia, tremor, and dyskinesia, using critical health and wellness data from Apple Watch. NeuroRPM is able to assess even slight changes with accuracy comparable to that of a neurologist. This changes the game for the treatment of Parkinson’s patients.

NeuroRPM will transform the way Parkinson’s disease is monitored and managed. NeuroRPM consists of proprietary algorithms integrated into an Apple Watch app, that collects data passively through the user’s everyday use of the easy-to-use app. The app is a convenient and effective way to continuously monitor symptoms and health metrics of Parkinson’s disease. NeuroRPM is available by prescription, and only uses data from Apple Watch that users have chosen to share with the app.

“We are thrilled to be on the new frontier of digital health with NeuroRPM. By leveraging the power of Apple Watch, we are transforming the way individuals with Parkinson’s disease understand their health, enabling care providers to make more informed clinical decisions which will lead to better health outcomes. We are honored to help drive this revolution in healthcare,” said NeuroRPM President, Atila Omer.

NeuroRPM is the culmination of years of intellectual property development, clinical trials and technical research and represents a major advancement in the management of Parkinson’s disease.

If you would like to learn more about NeuroRPM and interested in using the app, please visit www.NeuroRPM.com for more information.

About NeuroRPM Inc.

NeuroRPM Inc. is a digital health company focused on developing solutions to improve clinical care. The company’s flagship product, NeuroRPM, uses AI and machine learning to monitor Parkinson’s disease.

Contacts

Atila Omer, 412-478-1075

atila.omer@neurorpm.com

Staff

Recent Posts

Live IP Broadcast Equipment Market Size to Grow USD 5.66 Billion by 2031 | 17.6% CAGR

NEW YORK, June 16, 2025 /PRNewswire/ -- According to a new comprehensive report from The…

34 minutes ago

XPPen Partners with Annecy International Animation Film Festival to Launch the Inaugural XPPen Award for Graduation Films, Nurturing the Next-Gen Talent

LOS ANGELES, June 16, 2025 /PRNewswire/ -- XPPen, the leading digital art innovation brand, is…

34 minutes ago

Banuba Enhances Video Editor SDK with Templates to Ease Content Creation

DUBAI, United Arab Emirates--(BUSINESS WIRE)--#ARTechnology--Banuba, a leading augmented reality company, renowned for its cutting-edge video…

8 hours ago

Panasonic Professional Video & Audio Systems Names Caroline Niedzwiecki as Director of Sales

Caroline to oversee North American sales for Panasonic’s video and audio businessNEWARK, N.J.--(BUSINESS WIRE)--Panasonic Entertainment…

8 hours ago

Gentex Corporation Announces Agreements With New Partners for Ops-Core® RAILINK® Power and Data ARC Rail System

License agreements signed with new development partners for Integrated Headborne PlatformCARBONDALE, Pa.--(BUSINESS WIRE)--Gentex Corporation, a…

8 hours ago

High-Impact Workshops and Lecture Series Announced for World of Coffee Geneva 2025

Actionable Learning Opportunities Focus on the Specialty Coffee Value Chain GENEVA, SWITZERLAND / ACCESS Newswire…

14 hours ago